The Commercial Eyes Access team recently had the opportunity to attend a seminar ‘Should we use a different HTA process for rare disease treatments?’ organised by Melbourne University, led by renowned health economist Professor Michael Drummond. Here we present some of the key take-aways from this talk along with insights on this important topic.
Navigating the Australian Medical Device Market in 2024
Australia stands out as an attractive market for medical devices due to its mature, well-funded, and stable healthcare system. However, breaking into this market is not without its intricacies and…
Productlife Group Acquires Commercial Eyes, Expanding Its Footprint In The APAC Region
ProductLife Group expands its expertise in APAC through the acquisition of Commercial Eyes, Australia’s leading pharmaceutical and medical device commercialisation company, specialising in regulatory affairs, pharmacovigilance, medical information, quality assurance,…
Leading Healthcare Transformation through Innovative Solutions
Healthcare transformation requires innovative solutions. Through our Service Blueprinting work, we align people, process, and tech to measure and improve health and commercial outcomes. Read more about how Commercial Eyes…
12 Insights from the Recent Australian Digital Health Blueprint and Action Plan Launch
In December 2023, the Australian Federal Department of Health and Aged Care released their digital health blueprint and action plan. Commercial Eyes has identified 12 insights that have short- and…
Events & Webinars, Hot Topics,
Navigating the Future of Patient Safety: Insights from ISOP Global Congress in Bali
Earlier this month, Commercial Eyes’ Patient Safety Manager, Duncan Maher participated in a range of workshops and networking events to prepare and design for the future of Patient Safety and…
Unlocking the Power of Transparency: Competitive Intelligence and the Birth of TRoVE (TRansfer of ValuE)
At Commercial Eyes, we are dedicated to staying at the forefront of the pharmaceutical and healthcare industry by developing innovative tools and frameworks that provide valuable insights for our clients. Our…
Having the Right QPPV Is Essential to Meeting Pharmacovigilance Obligations
Ensuring the right QPPV is crucial for meeting pharmacovigilance obligations in an evolving landscape of therapeutic goods….
Eyes on Health Economics: A Deep Dive by Commercial Eyes
An Introduction to Economic Evaluation for Pharma…
Navigating the Complexities: Health Technology Assessment for Rare Diseases
The Commercial Eyes Access team recently had the opportunity to attend a seminar ‘Should we use a different HTA process for rare disease treatments?’ organised by Melbourne University, led by…
Elevating Patient Voices for Safer Healthcare: Commercial Eyes’ Commitment on World Patient Safety Day 2023
On World Patient Safety Day 2023, we proudly stand with the global healthcare community, and our clients to Elevate the voice of…
Extension to TGA Transition Periods for Reclassified Devices and Patient-Matched Devices
The Therapeutic Goods Administration (TGA) recently announced that they have received Government approval to extend the transition period affecting most reclassified devices, as well as patient-matched devices, extending the deadline…
Commercial Eyes Appoints New General Manager
We are excited to announce Tanya van der Wall as our new General Manager. With her extensive experience and deep understanding of the industry, Tanya will lead our expert team…
World Health Day 2023
On World Health Day 2023, the Commercial Eyes team reflects on the importance of accessing healthcare and how available and supportive wellbeing programs can positively impact our…
Understanding Patient Perspectives: The First in our Ongoing Patient Survey Series
In recent years there has been a shift in healthcare towards a more ‘patient-centric’ approach. However despite this shift, there remains a limited understanding of patients’ perspectives. Here we present…
Supporting Our Support Workers
Social workers provide vital support in the healthcare cycle, helping with treatment plans and being a critical communicative link between patients and HCPs. This link can be used to help…
Developments in Thought-Leadership
Identifying the right thought leader is critical in Medical Communications, and with the shift to omnichannel marketing, these leaders are finding new mediums to engage and influence scientific…
International Women’s Day 2023
Commercial Eyes was built on the foundation of a flexible business model designed to embrace and empower the incredible women in our…
Significant TGA Fee Increases for Medical Devices in FY24
The Therapeutic Goods Administration (TGA) have released its consultation paper on the proposed fees & charges model for the 2023-24 Financial…
Commercial Eyes focuses on Rare Disease Day 2023
On Rare Disease Day 2023, the Commercial Eyes team stands with the rare disease community and recognise their strength and resilience. We encourage all stakeholders to work together to support…
2023 Kosi Challenge with Rare Cancers Australia
Commercial Eyes to join Rare Cancers Australia in our first Kosi Challenge. The work we do every day with clients and stakeholders confirms how devastating cancer is to the Australian community….